112 related articles for article (PubMed ID: 9379997)
1. Bromfenac for analgesia.
Med Lett Drugs Ther; 1997 Oct; 39(1011):93-4. PubMed ID: 9379997
[No Abstract] [Full Text] [Related]
2. Comparison of tilidine/naloxone, tramadol and bromfenac in experimental pain: a double-blind randomized crossover study in healthy human volunteers.
Högger P; Rohdewald P
Int J Clin Pharmacol Ther; 1999 Aug; 37(8):377-85. PubMed ID: 10475140
[TBL] [Abstract][Full Text] [Related]
3. Clinical pharmacokinetics and pharmacodynamics of bromfenac.
Skjodt NM; Davies NM
Clin Pharmacokinet; 1999 Jun; 36(6):399-408. PubMed ID: 10427465
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of bromfenac in healthy subjects after single oral administration of three different doses.
Högger P; Rohdewald P
Arzneimittelforschung; 1993 Oct; 43(10):1114-8. PubMed ID: 8267679
[TBL] [Abstract][Full Text] [Related]
5. Global experience with Xibrom (bromfenac ophthalmic solution) 0.09%: the first twice-daily ophthalmic nonsteroidal anti-inflammatory drug.
Donnenfeld ED; Donnenfeld A
Int Ophthalmol Clin; 2006; 46(4):21-40. PubMed ID: 17060789
[No Abstract] [Full Text] [Related]
6. The effect of food on bromfenac, naproxen sodium, and acetaminophen in postoperative pain after orthopedic surgery.
Forbes JA; Sandberg RA; Bood-Björklund L
Pharmacotherapy; 1998; 18(3):492-503. PubMed ID: 9620100
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of bromfenac for the treatment of corneal ulcer pain.
Schechter BA; Trattler W
Adv Ther; 2010 Oct; 27(10):756-61. PubMed ID: 20845001
[TBL] [Abstract][Full Text] [Related]
8. Bromfenac, a new nonsteroidal anti-inflammatory drug: relationship between the anti-inflammatory and analgesic activity and plasma drug levels in rodents.
Nolan JC; Osman MA; Cheng LK; Sancilio LF
J Pharmacol Exp Ther; 1990 Jul; 254(1):104-8. PubMed ID: 2366177
[TBL] [Abstract][Full Text] [Related]
9. Gastrointestinal blood loss induced by bromfenac sodium, aspirin, and placebo.
Cohen A
Clin Ther; 1995; 17(6):1110-7. PubMed ID: 8750402
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic-pharmacodynamic relationships of bromfenac in mice and humans.
Chiang ST; Ermer JC; Osman M; Chau T; Hicks D; Wheeler S; Vavra I
Pharmacotherapy; 1996; 16(6):1179-87. PubMed ID: 8947993
[TBL] [Abstract][Full Text] [Related]
11. A dose-ranging study of bromfenac sodium in oral surgery pain.
Hersh EV; Cooper SA; Levin LM; Betts NJ; Wedell D; Lamp C; Wajdula J
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1998 Jul; 86(1):36-41. PubMed ID: 9690243
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of pharmacokinetic interaction between bromfenac and phenytoin in healthy males.
Gumbhir-Shah K; Cevallos WH; DeCleene SA; Korth-Bradley JM
J Clin Pharmacol; 1997 Feb; 37(2):160-8. PubMed ID: 9055143
[TBL] [Abstract][Full Text] [Related]
13. Concentration and dosing of ketorolac versus bromfenac.
Gayton J
J Cataract Refract Surg; 2009 Jul; 35(7):1319; author reply 1320. PubMed ID: 19545832
[No Abstract] [Full Text] [Related]
14. Comparison of cyclooxygenase inhibitory activity and ocular anti-inflammatory effects of ketorolac tromethamine and bromfenac sodium.
Waterbury LD; Silliman D; Jolas T
Curr Med Res Opin; 2006 Jun; 22(6):1133-40. PubMed ID: 16846546
[TBL] [Abstract][Full Text] [Related]
15. [One case of corneal melting after instillation of bromfenac 0.09%].
Troumani Y; Beral L; Glatre F; Finke E; David T
J Fr Ophtalmol; 2014 Oct; 37(8):e125-7. PubMed ID: 24838029
[No Abstract] [Full Text] [Related]
16. Comparison of ketorolac 0.4% and bromfenac 0.09% at trough dosing: aqueous drug absorption and prostaglandin E2 levels.
Bucci FA; Waterbury LD
J Cataract Refract Surg; 2008 Sep; 34(9):1509-12. PubMed ID: 18721711
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of bromfenac 0.075% formulated in DuraSite for pain and inflammation in cataract surgery.
Wentz SM; Price F; Harris A; Siesky B; Ciulla T
Expert Opin Pharmacother; 2019 Oct; 20(14):1703-1709. PubMed ID: 31343372
[No Abstract] [Full Text] [Related]
18. Bromfenac (Duract)-associated hepatic failure requiring liver transplantation.
Hunter EB; Johnston PE; Tanner G; Pinson CW; Awad JA
Am J Gastroenterol; 1999 Aug; 94(8):2299-301. PubMed ID: 10445569
[TBL] [Abstract][Full Text] [Related]
19. Fatal fulminant hepatitis associated with bromfenac use.
Rabkin JM; Smith MJ; Orloff SL; Corless CL; Stenzel P; Olyaei AJ
Ann Pharmacother; 1999 Sep; 33(9):945-7. PubMed ID: 10492497
[TBL] [Abstract][Full Text] [Related]
20. A crossover comparison of bromfenac sodium, naproxen sodium, and placebo for relief of pain from primary dysmenorrhea.
Mehlisch DR; Fulmer RI
J Womens Health; 1997 Feb; 6(1):83-92. PubMed ID: 9065377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
